Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations.
Elvebakken H, Perren A, Scoazec JY, Tang LH, Federspiel B, Klimstra DS, Vestermark LW, Ali AS, Zlobec I, Myklebust TÅ, Hjortland GO, Langer SW, Gronbaek H, Knigge U, Tiensuu Janson E, Sorbye H. Elvebakken H, et al. Among authors: myklebust ta. Neuroendocrinology. 2021;111(9):883-894. doi: 10.1159/000511905. Epub 2020 Oct 1. Neuroendocrinology. 2021. PMID: 33002892
Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
Stensvold E, Krossnes BK, Lundar T, Due-Tønnessen BJ, Frič R, Due-Tønnessen P, Bechensteen AG, Myklebust TÅ, Johannesen TB, Brandal P. Stensvold E, et al. Among authors: myklebust ta. Acta Oncol. 2017 May;56(5):698-705. doi: 10.1080/0284186X.2017.1301679. Epub 2017 Mar 21. Acta Oncol. 2017. PMID: 28325133
Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival.
Stensvold E, Myklebust TÅ, Cappelen J, Due-Tønnessen BJ, Due-Tønnessen P, Kepka A, Johannesen TB, Krossnes B, Lundar T, Maric S, Miletic H, Moholdt V, Myrmel KS, Nordberg T, Rydland J, Stokland T, Solem K, Solheim O, Torsvik I, Wikran GC, Zeller B, Wesenberg F, Bechensteen AG, Brandal P. Stensvold E, et al. Among authors: myklebust ta. Pediatr Blood Cancer. 2019 Oct;66(10):e27910. doi: 10.1002/pbc.27910. Epub 2019 Jul 1. Pediatr Blood Cancer. 2019. PMID: 31264356
Can different definitions of date of cancer incidence explain observed international variation in cancer survival? An ICBP SURVMARK-2 study.
Myklebust TÅ, Andersson T, Bardot A, Vernon S, Gavin A, Fitzpatrick D, Jerm MB, Rutherford M, Parkin DM, Sasieni P, Arnold M, Soerjomataram I, Bray F, Lambert PC, Møller B. Myklebust TÅ, et al. Cancer Epidemiol. 2020 Aug;67:101759. doi: 10.1016/j.canep.2020.101759. Epub 2020 Jun 13. Cancer Epidemiol. 2020. PMID: 32544801 Free article.
MGMT Gene Promoter Methylation Status - Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas.
Johannessen LE, Brandal P, Myklebust TÅ, Heim S, Micci F, Panagopoulos I. Johannessen LE, et al. Among authors: myklebust ta. Cancer Genomics Proteomics. 2018 Nov-Dec;15(6):437-446. doi: 10.21873/cgp.20102. Cancer Genomics Proteomics. 2018. PMID: 30343277 Free PMC article. Clinical Trial.
140 results